Skip to content
Menu

Ernexa Therapeutics Inc. ERNA

Full chart Compare
Set alert

Price alert · ERNA

All alert types
1.36 USD -0.27 (-16.56%)

Regular-session close

1.35 -0.01 -0.74%

After hours · Nov 20, 4:00 PM ET

1.35 Day range 1.60
1.36 52-week range 37.00
YTD
-95.47%
1 year
-95.75%

5D -0.47 (-24.35%)

1.401.601.80MonTueWedThuFri1.46
Market cap
2.30M
Revenue (ttm)
162.00K
EPS (ttm)
-11.22
Shares out
51.37M
Forward P/E
-0.03
YTD return
-95.47%
1-year return
-95.75%
Volume
20.38K
Avg volume
44.69K
Open
1.60
Previous close
1.63
Day's range
1.35 – 1.60
52-week range
1.36 – 37.00
Beta
7.77

Key statistics

50-day average
0.7302
200-day average
1.58
Enterprise value
51.71M
Price / sales
77.82
Price / book
0.59
Free cash flow
-11.78M
Total cash
2.59M
Total debt
49.20M
Short % of float
0.09%

Fundamental scorecard

4 of 25 checks passed on ERNA’s reported financials

ValueGrowthProfitabilityHealthDividend

4of 25 checks passed

  • Value 1 of 5
  • Growth 0 of 5
  • Profitability 0 of 5
  • Financial health 3 of 5
  • Dividend 0 of 5

Statements to Sep 30, 2026.

Financials — quick view

All financials
ERNA Revenue — quarterly 0
ERNA Net income — quarterly -2.94M
ERNA EPS — quarterly -1.89

Earnings

ERNA recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 12, 2024Sep 1, 20240.00-4.92——
Aug 13, 2024Jun 1, 20240.00-1.02——
May 14, 2024Mar 1, 20240.00-1.23——
Mar 14, 2024Dec 1, 20230.00-1.14——
Nov 13, 2023Sep 1, 20230.00-1.03——
Aug 11, 2023Jun 1, 20230.00-0.85——

About Ernexa Therapeutics Inc.

Eterna Therapeutics Inc., a life science company, provides mRNA cell engineering technologies. Its technologies include mRNA cell reprogramming and gene editing; NoveSlice and UltraSlice gene-editing proteins; and the ToRNAdo mRNA delivery system. The company has a license agreement with Factor Bioscience Limited. Eterna Therapeutics Inc. was founded in 2018 and is based in Cambridge, Massachusetts.

Sector
Healthcare
Industry
Biotechnology
Country
United States
Website
eternatx.com

News

No recent headlines

Headlines appear here as they are published.

Your note

Sign in to keep a note on ERNA — it syncs with the Stock Master app.

Insider holders

ERNA insider holders
InsiderRelationLatest transactionDateShares held
CHERINGTON CHARLESBeneficial Owner of more than 10% of a Class of SecurityConversion of Exercise of derivative securityOct 28, 202416,628,100
GURROLA SANDRA MOfficerConversion of Exercise of derivative securityJun 20, 20241,185

Institution ownership

ERNA institution ownership
Holder% heldSharesValueReported
Corient Private Wealth LLC0.51%262,86264.51KSep 29, 2024
Cypress Point Wealth Management, LLC0.18%94,37523.16KSep 29, 2024
UBS Group AG0.16%83,62020.52KSep 29, 2024
Naviter Wealth, LLC0.15%78,79619.34KSep 29, 2024
Sippican Capital Advisors0.13%68,50416.81KSep 29, 2024
Two Sigma Securities, LLC0.06%32,8608.06KSep 29, 2024

Fund ownership

ERNA fund ownership
Holder% heldSharesValueReported
Vanguard Extended Market Index Fund0.05%26,0996.40KSep 29, 2024
Fidelity Extended Market Index Fund0.03%13,0973.21KOct 30, 2024
Fidelity Series Total Market Index Fund0.01%3,129767Oct 30, 2024
Guggenheim Active Allocation Fund0.00%81Aug 30, 2024
Fidelity Total Market Index Fund0.00%2,047502Oct 30, 2024